Publications

18 Jul 2010
News

Renewed focus on finance

03 Sep 2009
What Do You Think?

Are Retention Bonuses Worth the Investment?

Summing Up What is the time and place for retention bonuses? Retention bonuses have their time and place but have to be used sparingly, according to many respondents to this month's column. Others were not... View Details

Keywords: by Jim Heskett

11 Dec 2015
News

Airbnb hosts discriminate against black people, study finds

January 2015
Case

The Blonde Salad

By: Anat Keinan, Kristina Maslauskaite, Sandrine Crener and Vincent Dessain

In 2014, Chiara Ferragni, a globe-trotting founder of the world's most popular fashion blog The Blonde Salad, and Riccardo Pozzoli, her co-founder and business partner, had to decide how to best monetize her blog as well as her shoe line called the "Chiara Ferragni... View Details

December 1973 (Revised June 1982)
Case

MRC, Inc. (A)

MRC must place a value on an acquisition prospect and also decide whether a deal makes sense from strategic and organizational perspectives. An updated version of and earlier case by W.E. Fruhan, Jr. and J.H. McArthur. View Details

Keywords: Strategic Planning; Valuation; Acquisition

Leslie Perlow discusses with Adam Grant how to think about flexibility in this new hybrid world where flexibility more than ever is not just about time but also place of work. View Details

01 Mar 2021
Blog Post

Best Practices for Creating a Successful Virtual Internship

In the wake of COVID-19, organizations around the world quickly made changes to how they got work done, including managing summer internships. For many organizations, that meant creating remote internship programs in 2020 that will stay in View Details

Keywords: All Industries

30 Jul 2007
Research & Ideas

Repugnant Markets and How They Get That Way

similarly the story about kidneys: why I can't buy yours, although I could accept it as a gift. Repugnance is different in different places and at different times. I feel a little bit like a sociologist when I look at these things. Q:... View Details

Keywords: by Martha Lagace

August 2019 (Revised August 2024)
Case

The Walt Disney Company: Theme Parks

By: Rory McDonald, Allison Mnookin and Iuliana Mogosanu

As he seeks to place the division he leads on a firm footing for the future, Tom Staggs, chairman of Walt Disney Parks and Resorts, is considering a range of investments designed either to upgrade the guest experience in the company’s existing parks or to expand access... View Details

Keywords: Entertainment; Investment; Expansion; Decision Making; Customer Satisfaction; Entertainment and Recreation Industry

November 2008
Case

Syngenta International AG: Tropical Sugar Beet

By: Ray A. Goldberg and Alwin R. Kopse

Syngenta has developed a new sugar beet crop especially useful to tropical climates that enable double cropping to take place and provide both food and energy from the soil. Thus both the governments of Colombia and India are enthused about the new technological... View Details

Keywords: Food; Government and Politics; Technological Innovation; Performance Improvement; Performance Productivity; Research and Development; Environmental Sustainability; Technology Adoption; India; Colombia

16 May 2013
News

Harvard study finds U.S. losing edge on jobs

Blog

How We Are Keeping HBS—and Our Program Participants—Healthy

A New Normal on Campus This fall, HBS officially welcomed MBA students and Executive Education program participants back to campus after an 18-month pandemic hiatus. To ensure that faculty, students and staff feel confident about their long-awaited return to campus,... View Details

March 2002 (Revised May 2002)
Case

Genzyme: Engineering the Market for Orphan Drugs

Genzyme has made money with external technology in orphan drug markets generally considered to be too small to be attractive to other drug companies. Now competition is entering these same markets, placing Genzyme's business model under new pressures. View Details

Keywords: Business Model; Information Technology; Market Entry and Exit; Biotechnology Industry; Pharmaceutical Industry